Viral hepatitis is an infection that causes inflammation of the liver. It can be caused by different viruses, including hepatitis B virus (HBV) and hepatitis C virus (HCV). Both HBV and HCV can cause acute and chronic infections and are leading causes of liver cirrhosis and hepatocellular carcinoma.
Since the end of October 2022 and as of week 47, several EU/EEA countries have indicated an increase in paediatric hospitalisations due to RSV infections causing bronchiolitis, amidst concurrent circulation of other respiratory pathogens, such as the influenza and SARS-CoV-2 viruses.
In recent weeks, respiratory syncytial virus (RSV) circulation in the EU/EEA has intensified, with increasing transmission rates in all population groups and an earlier-than-usual start of the season. Several EU/EEA countries are experiencing high RSV circulation and the number of severe acute respiratory infections (SARI) due to RSV is increasing. At this time of the year RSV infections are not unusual, however this year there is more RSV activity and it began earlier than in pre-COVID-19 seasons.
This issue of the ECDC Communicable Disease Threats Report (CDTR) covers the period 4 – 10 December 2022 and includes updates on COVID-19, Ebola virus, respiratory syncytial virus, streptococcal infection, diphtheria, seasonal influenza, mpox (monkeypox), hepatitis, MERS-CoV, meningitis, and mass gathering monitoring at the FIFA World Cup 2022 Qatar.
This issue of the CDTR covers the period 27 November – 3 December 2022 and includes updates on COVID-19, Ebola, diphtheria, respiratory syncytial virus, seasonal influenza, monkeypox, mass gathering monitoring at the FIFA World Cup 2022 Qatar, Chikungunya, dengue, Shigella sonnei, poliomyelitis, meningitis, cholera.
The 2022-2023 influenza (flu) season epidemic is off to an early start in the European region as concerns over Respiratory syncytial virus (RSV) rise and COVID-19 is still being a threat.